BioCentury
ARTICLE | Company News

CiVentiChem, DFH Pharma deal

January 16, 2012 8:00 AM UTC

DFH selected CRO CiVentiChem to provide "medicinal chemistry services" to support DFH's efforts to develop next-generation HIV maturation inhibitor products. DFH said the deal will "expedite the disco...